Grant: Engage Grants Program
University of Manitoba
$25,000.00
Investigation of the anti-inflammatory potential of novel anti-infective peptides
EF 2010-11
Résumé
Chronic inflammation is the characteristic feature of a wide range of diseases including Rheumatoid arthritis,
inflammatory bowel disease, proriasis etc. Treatment options for these diseases are currently limited due to the
complexity of the disease and our limited understanding of suitable targets for interference in chronic
inflammation. Current treatments focus on inhibition of key molecules that are important in both inflammation
and function of the immune system, resulting in many patients being more vulnerable to opportunistic
infections and tumours. Therefore alternative strategies are needed to overcome the limitation with current
immunosuppressive treatments. This research proposal will focus on understanding the potential of a group of
peptides that play a role in both immune responses and inflammation. In our laboratory, several screening
models have already been established for studying the effects of small molecules such as peptides proposed in
this study, in selectively limiting inflammatory responses without compromising immunity. In this study, the
anti-inflammatory mode of action of novel anti-infective peptides provided by Cangene Corporation will be
investigated. The results will demonstrate whether these peptides can selectively suppress inflammatory
responses while maintaining key elements of host immunity required for resolution of infections. The results
from this study will strongly support future research into examining this class of molecules as an alternate
strategy for management of chronic inflammatory diseases. This study will also aid in the identification of new
molecular targets for anti-inflammatory agents for these complex diseases.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
404937-2010
Name nom
Mookherjee, Neeloffer
Department département
Medicine, Faculty of
Organization id
19
Institution établissement
University of Manitoba
Province en
Manitoba
Province fr
Manitoba
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2010
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1555
Committee name en
Prairie Internal Decision Committee
Committee name fr
Comité de décision interne pour les Prairies
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
6400
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Life sciences research related to human health and disease
Research subject fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Partie
1
Nb partie
1
Application title
Investigation of the anti-inflammatory potential of novel anti-infective peptides
Keyword
NSERC
Application summary
Chronic inflammation is the characteristic feature of a wide range of diseases including Rheumatoid arthritis,
inflammatory bowel disease, proriasis etc. Treatment options for these diseases are currently limited due to the
complexity of the disease and our limited understanding of suitable targets for interference in chronic
inflammation. Current treatments focus on inhibition of key molecules that are important in both inflammation
and function of the immune system, resulting in many patients being more vulnerable to opportunistic
infections and tumours. Therefore alternative strategies are needed to overcome the limitation with current
immunosuppressive treatments. This research proposal will focus on understanding the potential of a group of
peptides that play a role in both immune responses and inflammation. In our laboratory, several screening
models have already been established for studying the effects of small molecules such as peptides proposed in
this study, in selectively limiting inflammatory responses without compromising immunity. In this study, the
anti-inflammatory mode of action of novel anti-infective peptides provided by Cangene Corporation will be
investigated. The results will demonstrate whether these peptides can selectively suppress inflammatory
responses while maintaining key elements of host immunity required for resolution of infections. The results
from this study will strongly support future research into examining this class of molecules as an alternate
strategy for management of chronic inflammatory diseases. This study will also aid in the identification of new
molecular targets for anti-inflammatory agents for these complex diseases.